India is funding biotech startups, but investors aren't coming back: Kiran Mazumdar-Shaw explains why – Business Today
India is funding biotech startups, but investors aren't coming back: Kiran Mazumdar-Shaw explains why Business Today…
India is funding biotech startups, but investors aren't coming back: Kiran Mazumdar-Shaw explains why Business Today…
India overhauls drug patent guidelines to curb evergreening and speed up cheap generics Livemint Read the…
Pharma haircare market in India finds its growth roots in young patients Business Standard Read the…
Aurobindo joins speciality pharma race as Indian drugmakers return to branded US play Moneycontrol.com Read the…
India’s Pharma Sector Must Go Beyond Generics, Pursue Greater R&D and Innovation: Piyush Goyal DD News…
Evonile Pharma Approves Fundraising of Up to Rs 900 Crore Through Rights Issue Medical Dialogues Read…
Biocon’s Kiran Mazumdar-Shaw Calls for India’s Pharma Industry to Shift from Generics to Innovation Chemical Industry…
A Bitter Pill of Accountability India Legal Read the full story at source →
India’s pharma tech leaders to convene at 15th Pharma IT Summit in Mumbai Indian Pharma Post…
Fadnavis praises AstraZeneca for opening Mumbai office, thanks pharma company for COVID-19 vaccine The Statesman Read…